Literature DB >> 33245179

Daratumumab in T-cell acute lymphoblastic leukaemia: A case report and review of the literature.

Sandra D Ruhayel1, Santosh Valvi1.   

Abstract

Entities:  

Year:  2020        PMID： 33245179     DOI： 10.1002/pbc.28829

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  3 in total

1.  Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.

Authors:  Marco Cerrano; Massimiliano Bonifacio; Matteo Olivi; Antonio Curti; Michele Malagola; Michelina Dargenio; Anna Maria Scattolin; Cristina Papayannidis; Fabio Forghieri; Carmela Gurrieri; Ilaria Tanasi; Patrizia Zappasodi; Roberta La Starza; Nicola Stefano Fracchiolla; Patrizia Chiusolo; Luisa Giaccone; Maria Ilaria Del Principe; Fabio Giglio; Marzia Defina; Claudio Favre; Carmelo Rizzari; Barbara Castella; Giovanni Pizzolo; Felicetto Ferrara; Sabina Chiaretti; Robin Foà
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941

Review 2.  A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies.

Authors:  Haley Newman; David T Teachey
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

Review 3.  Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies.

Authors:  Ioannis Kyriakidis; Eleni Vasileiou; Claudia Rossig; Emmanuel Roilides; Andreas H Groll; Athanasios Tragiannidis
Journal:  J Fungi (Basel)       Date:  2021-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.